Profile Picture
  • All
  • Search
  • Images
  • Videos
  • Maps
  • News
  • Copilot
  • More
    • Shopping
    • Flights
    • Travel
  • Notebook
  • Top stories
  • Sports
  • U.S.
  • Local
  • World
  • Science
  • Technology
  • Entertainment
  • Business
  • More
    Politics
Order byBest matchMost fresh
  • Any time
    • Past hour
    • Past 24 hours
    • Past 7 days
    • Past 30 days
ascopubs.org
6y

Early progression (progr) in patients (pts) with metastatic pancreatic cancer (mPaC) and a germline BRCA mutation (gBRCAm): Phase III POLO trial of olaparib (O) versus placebo (P).

Molecular genetic changes in solid pseudopapillary neoplasms (SPN) of the pancreas.

Some results have been hidden because they may be inaccessible to you

Show inaccessible results

Trending now

FCC OKs Nexstar-Tegna deal
Action legend Norris dies
Trump issues executive order
Regrets Epstein friendship
Loyola student fatally shot
Suspends Georgia’s gas tax
Georgia Tech hires new coach
Calvin Tomkins dies
Found guilty of 2019 murder
US sends more troops to ME
Iran hits Kuwait refinery
DOJ seeks to dismiss charges
Ex-pro wrestler acquitted
To end radio news service
US prosecutors probe Petro
24 states sue EPA
Trump admin sues Harvard
US may lift Iran oil sanctions
Epstein’s ex-lawyer testifies
Unveils AI policy blueprint
Patriarch Filaret dies at 97
MBTA station incident
Israeli strikes hit Tehran
Missing US student found dead
Pulls troops from Iraq mission
Plans disaster response hubs
UBS secures US bank license
Co-founder, staff charged
Strike multi‑year deal
Judge blocks press policy
DHS funding bill rejected
Ties games-played mark
Arts panel approves gold coin
Warren endorses Platner
South Korean factory fire
Temporarily banned in NV
Close to meet Iran objectives?
  • Privacy
  • Terms